PROTOKINETIX BLOG

Find out how AAGP® is changing lives through cell survival

As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.

Apr 26, 2016

byncaipen

Transplants

ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP®

St. Marys, West Virginia ProtoKinetix, Incorporated (OTCQB: PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) outlines the steps to be completed for the application to conduct a clinical trial in Canada. For...Read more

Request More Information

Talk to a member of the ProtoKinetix team to learn more about our research and results.